COMMUNIQUÉS West-GlobeNewswire

Pluristem Signs Collaboration Agreement With Thermo Fisher Scientific
09/07/2018
HAIFA, Israel, July 09, 2018 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading developer of placenta-based cell therapy products, announced today that it has entered into a strategic [...]
Sunesis Pharmaceuticals Strengthens Senior Management Team
09/07/2018
SOUTH SAN FRANCISCO, Calif., July 09, 2018 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced three key new management appointments as part of the Company’s expansion of its development team [...]
Aptose Biosciences to Participate at the Oppenheimer & Co. Inc. Boston Oncology Insight Summit and 1x1 Day
09/07/2018
SAN DIEGO and TORONTO, July 09, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS) today announced that William G. Rice, Ph.D., Chairman, President and Chief Executive Officer and Gregory Chow, [...]
G1 Therapeutics Expands Executive Leadership Team with Appointment of John Demaree as Chief Commercial Officer and Stillman Hanson as General Counsel
09/07/2018
RESEARCH TRIANGLE PARK, N.C., July 09, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq:GTHX), a clinical-stage oncology company, today announced appointments for two newly created executive leadership roles to [...]
Translate Bio Announces Closing of Collaboration and Licensing Agreement with Sanofi Pasteur to Develop mRNA Vaccines for Infectious Diseases
09/07/2018
LEXINGTON, Mass., July 09, 2018 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq:TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat [...]
Anavex Life Sciences Receives Approval to Initiate Phase 2 Clinical Trial of ANAVEX®2-73 for the Treatment of Parkinson’s Disease Dementia
09/07/2018
Primary Endpoint Cognition with Secondary Endpoints Parkinsonian Motor Symptoms and Sleep Function during 14-Week Study NEW YORK, July 09, 2018 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company [...]
Zynerba Pharmaceuticals Initiates CONNECT-FX, a Pivotal Clinical Trial of ZYN002 in Fragile X Syndrome
09/07/2018
Study will Evaluate the Efficacy and Safety of Transdermally-Delivered Cannabidiol (CBD) in Children and Adolescents with Fragile X Syndrome Top Line Results Expected in Second Half of 2019 Zynerba to host conference [...]
TRU NIAGEN® to be featured at the American Association of Naturopathic Physicians Annual Convention and the 2018 Healthy Aging Summit
09/07/2018
Participation at two mid-July events will target healthcare practitioners IRVINE, Calif., July 09, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to [...]
Athenex Names Timothy Cook as Senior Vice President of Global Commercial Oncology
09/07/2018
Mr. Cook was Previously VP and Chief Operating Officer of Oncology at Lilly BUFFALO, N.Y., July 09, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq:ATNX), a global biopharmaceutical company dedicated to the discovery, [...]
Amphastar Announces Expansion of Amphastar Nanjing Pharmaceuticals Inc.
09/07/2018
RANCHO CUCAMONGA, Calif., July 09, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced business expansion plans for its subsidiary, Amphastar Nanjing Pharmaceuticals Inc. (“ANP”). To date, [...]
Novo Nordisk A/S - Share repurchase programme
09/07/2018
Bagsværd, Denmark, 9 July 2018 - On 4 May 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR), [...]
New legal entity for LIDDS license partner in China
09/07/2018
LIDDS has agreed to transfer the licensing agreement for Liproca® Depot in China to Jiangxi Puheng Pharmaceuticals Ltd following a request from the owners of Jiangsu Ambition Medical. The change of legal entity will not [...]
Shire plc : Rule 2.9 Announcement
09/07/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 9 July 2018 Shire [...]
Galapagos announces design for PINTA Phase 2 trial with GLPG1205 in IPF
09/07/2018
Mechelen, Belgium; 9 July 2018; 7.30 CET - Galapagos NV (Euronext & NASDAQ: GLPG) announces the PINTA Phase 2 trial design with its GPR84 inhibitor GLPG1205 in patients with idiopathic pulmonary fibrosis (IPF). [...]
Cytori Reports Sustained Benefit of Cell Therapy in Erectile Dysfunction Trial
09/07/2018
Benefit Observed at 12 months Postoperatively Following Single Administration SAN DIEGO, July 09, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (Nasdaq:CYTX) announced publication in the peer-reviewed journal, [...]
Axovant Announces Global Licensing Agreement for AXO-AAV-OPMD Program for Treatment of Oculopharyngeal Muscular Dystrophy and Broader Platform Collaboration with Benitec Biopharma
09/07/2018
License grants Axovant worldwide rights to AXO-AAV-OPMD utilizing proprietary Silence-and-Replace technology, which suppresses mutant protein production while restoring expression of functional protein Plan to initiate [...]
National Lipid Association Announces Recipients of 2018-19 Junior Faculty Research Awards
06/07/2018
Nathan O. Stitziel, M.D., Ph.D., Soumik BasuRay, Ph.D., each earn two-year grant for lipid disorder research JACKSONVILLE, Fla., July 06, 2018 (GLOBE NEWSWIRE) -- The National Lipid Association announced on Friday the [...]
John Inadomi, MD is Honored by the American Health Council for “Best in Medicine”
06/07/2018
NEW YORK, July 06, 2018 (GLOBE NEWSWIRE) -- The American Health Council is proud to honor John Inadomi, MD as “America’s Best Doctor” for his contributions to the gastrointestinal field. Currently a professor of [...]
Abiomed First Quarter Fiscal 2019 Earnings And Conference Call Notification
06/07/2018
DANVERS, Mass., July 06, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc . (NASDAQ:ABMD) announced that on Thursday, July 26, 2018, the Company will release financial results for the first quarter of fiscal 2019. The Company will [...]

Pages